Author

Hausheer FH

HAUSHEER BIOMED - Cited by 5,092 - Oncology - drug development - pharmacology - physiology - biophysics

Biography

Hausheer FH is working as research scholar in BioNumerik Pharmaceuticals, Inc., 8122 Datapoint Drive Suite 1250, San Antonio, TX 78229, USA. His international experience includes various programs, contributions and participation in different countries for diverse fields of study.  His research interests reflect in his wide range of publications in various national and international journals.
Title
Cited by
Year
Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02
K Shimozuma, Y Ohashi, A Takeuchi, T Aranishi, S Morita, K Kuroi, ...Supportive care in cancer 17, 1483-1491, 2009200
189
2009
Types and epidemiology of cancer-related neuropathic pain: the intersection of cancer pain and neuropathic pain
MJ Lema, KM Foley, FH HausheerThe oncologist 15 (S2), 3-8, 2010201
134
2010
Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized …
K Shimozuma, Y Ohashi, A Takeuchi, T Aranishi, S Morita, K Kuroi, ...Supportive Care in Cancer 20, 3355-3364, 2012201
109
2012
Assessment of cancer-related neuropathy and neuropathic pain
CS Cleeland, JT Farrar, FH HausheerThe Oncologist 15 (S2), 13-18, 2010201
88
2010
Chemoprotective methods
FH HausheerUS Patent 8,143,236, 2012201
37
2012
Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of gamma-glutamyl transpeptidase
FH Hausheer, D Shanmugarajah, BD Leverett, X Chen, Q Huang, ...Cancer chemotherapy and pharmacology 65, 941-951, 2010201
23
2010
Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of human aminopeptidase N
FH Hausheer, AR Parker, PN Petluru, KW Jair, S Chen, Q Huang, X Chen, ...Cancer chemotherapy and pharmacology 67, 381-391, 111
20
2011
Monoazole ligand platinum analogs
Z Xiao, H Kochat, FH HausheerUS Patent 7,759,488, 2010201
17
2010
Chemoprotective methods and compositions
FH HausheerUS Patent 8,026,227, 2011201
17
2011
A recombinant reporter system for monitoring reactivation of an endogenously DNA hypermethylated gene
Y Cui, F Hausheer, R Beaty, C Zahnow, JP Issa, F Bunz, SB BaylinCancer research 74 (14), 3834-3843, 2014201
17
2014
Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with advanced non-small cell lung cancer
N Masuda, S Negoro, F Hausheer, K Nakagawa, K Matsui, S Kudoh, ...Cancer chemotherapy and pharmacology 67, 533-542, 2011201
12
2011
BNP7787-Mediated Modulation of Paclitaxel- and Cisplatin-Induced Aberrant Microtubule Protein Polymerization In vitro
AR Parker, PN Petluru, M Wu, M Zhao, H Kochat, FH HausheerMolecular cancer therapeutics 9 (9), 2558-2567, 2010201
12
2010
Cysteine specific targeting of the functionally distinct peroxiredoxin and glutaredoxin proteins by the investigational disulfide BNP7787
AR Parker, PN Petluru, VL Nienaber, J Badger, BD Leverett, K Jair, ...Molecules 20 (3), 4928-4950, 2015201
11
2015
Comprehensive Mcta-Analysis of Survival Outcomes from Two Randomized Multiccntcr Trials in First-Line Advanced Non-Small Cell Lung Cancer in Patients Treated with the Novel …
F Hausheer, S Bain, M Perry, L Du, Y Ohashi, Y Ariyoshi, M FukuokaAsia Pacific Journal of Oncology & Hematology 2 (1), 2010201
9
2010
Drugs for prophylaxis or mitigation of taxane-induced neurotoxicity
FH HausheerUS Patent ,710,095, 2014201
8
2014
C7-substituted camptothecin analogs
C-substituted camptothecin analogsK Narkunan, X Chen, H Kochat, F HausheerUS Patent ,68,496, 2010201
7
2010
Accumulation of BNP7787 in human renal proximal tubule cells
Accumulation of BNP8 in human renal proximal tubule cellsFH Hausheer, D Ding, D Shanmugarajah, BD Leverett, Q Huang, X Chen, ...Journal of pharmaceutical sciences 100 (9), 39-3984, 2011201
7
2011
Novel covalent modification of human anaplastic lymphoma kinase (ALK) and potentiation of crizotinib-mediated inhibition of ALK activity by BNP7787
AR Parker, PN Petluru, VL Nienaber, M Zhao, PY Ayala, J Badger, ...OncoTargets and therapy, 375-383, 2015201
6
2015
Stabilization of the Karenitecin® lactone by alpha-1 acid glycoprotein
S Yao, P Petluru, A Parker, D Ding, X Chen, Q Huang, H Kochat, ...Cancer Chemotherapy and Pharmacology 75, 719-728, 2015201
6
2015
Clinical evaluation of tavocept to decrease diuresis time and volume in dogs with bladder cancer receiving cisplatin
CJ Henry, BK Flesner, SA Bechtel, JN Bryan, DJ Tate, KA Selting, ...Journal of veterinary internal medicine 32 (1), 370-37, 2018201
6
2018

Referred From: https://scholar.google.com/citations?hl=en&user=8TvX-m4AAAAJ

Cited by
Citations 5092
h-index 34
i10-index 82
Recommended Journals
Open Access Journals